Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2011
08/09/2011US7994198 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase
08/09/2011US7994197 Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
08/09/2011US7994196 Indazole compound and pharmaceutical use thereof
08/09/2011US7994195 Therapeutic substituted piperidone compounds
08/09/2011US7994194 4-oxoquinoline derivatives
08/09/2011US7994193 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
08/09/2011US7994192 5-[3-(6,8-Dibromo-1,2,3,4-tetrahydro-quinolin-4-ylamino)-propylamino]-4H-thieno [3,2-b]pyridin-7-one, used as inhibitors of bacterial methionyl tRNA synthetase, administered for the treatment of bacterial infections; therapy for Clostridium difficile based infections
08/09/2011US7994191 Heterocyclic cyclopamine analogs and methods of use thereof
08/09/2011US7994190 Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
08/09/2011US7994189 Dihydropyridine derivatives
08/09/2011US7994188 Compounds for treating inflammatory diseases
08/09/2011US7994187 HIV inhibiting 3,4-dihydro-imidazo[4,5-B]pyridin-5-ones
08/09/2011US7994186 Pharmaceutical compositions containing camptothecins
08/09/2011US7994185 Benzene sulfonamide thiazole and oxazole compounds
08/09/2011US7994184 Small molecules that replace or agonize p53 function
08/09/2011US7994183 Solid preparation comprising 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluorobenzonitrile
08/09/2011US7994182 Quinazolinone-derivatives and their use for preparation of pharmaceutical compositions having PARP enzyme inhibitory effect
08/09/2011US7994181 6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
08/09/2011US7994180 Processes for preparing intermediates of pemetrexed
08/09/2011US7994179 Carbamoyl compounds as DGAT1 inhibitors 190
08/09/2011US7994178 X-ray powder diffraction pattern peaks at 4.7, 19.4 and 22.3 degrees; gastric juice solubility; flowability, tablet compaction
08/09/2011US7994177 Therapeutic agents useful for treating pain
08/09/2011US7994176 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
08/09/2011US7994175 Cosmetic use of 1-aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carboxamides and related compounds
08/09/2011US7994174 Pyridyl sulfonamides as modulators of ion channels
08/09/2011US7994173 2-piperazin-1-yl-3H-imidazo[4,5-b]pyridine derivatives
08/09/2011US7994172 [1H-pyrazolo[3, 4-D]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (P70s6k, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases
08/09/2011US7994171 Compounds for the treatment of hepatitis C
08/09/2011US7994170 1,3-dihydro-imidazo[4,5-C]quinolin-2-ones as lipid kinase inhibitors
08/09/2011US7994169 3,4-diaminopyridine derivatives for use as catalysts
08/09/2011US7994168 Hexahydro-pyrazino[1,2-A]pyrimidine-4,7-dione derivatives substituted with amino acids
08/09/2011US7994167 Pentafluorosulphanyl-substituted compound and its use for producing medicaments
08/09/2011US7994166 Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels for the treatment of pain
08/09/2011US7994165 Aryl aniline derivatives as β2 adrenergic receptor agonists
08/09/2011US7994164 Mineralocorticoid receptor antagonists and methods of use
08/09/2011US7994163 6-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists
08/09/2011US7994162 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same
08/09/2011US7994161 Derivatives of 2-alkoxy-3,4,5-trihydroxy-alkyl amides, preparation and use thereof, and compositions containing the same
08/09/2011US7994160 Pyridazine compounds as glycogen synthase kinase 3 inhibitors
08/09/2011US7994159 inhibits proliferation of c-Kit kinase activated-cancer; also mastocytosis, allergy and asthma, which are considered to be caused by c-Kit kinase; 4-(3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide
08/09/2011US7994158 Method for inhibiting tumor growth with dehydrosulphurenic acid extracted from Antrodia cinnamomea
08/09/2011US7994157 Controlling particle sizes; mixing with emulsifiers; melting, mixing
08/09/2011US7994156 Carboxylic acid 4-phenylazo-phenyl ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
08/09/2011US7994155 administering an accelerator for mineral (such as Na, K, Fe, Ca, Cu, Co, Zn, Se, Mg compoudnds) absorption containing a non-reducing saccharide composed of four glucose residues which cyclically bind each other via the alpha -1,3 and the alpha -1,6 linkages called as cyclic tetrasaccharide; food, drink
08/09/2011US7994154 Substituted liposaccharides useful in the treatment and prevention of endotoxemia
08/09/2011US7994153 Chloasma amelioration composition and dullness amelioration composition
08/09/2011US7994151 Compositions and methods for angiogenic therapy utilizing genes encoding ets-1
08/09/2011US7994148 Transmembrane delivery peptide and bio-material comprising the same
08/09/2011US7994147 Cellular genes regulated by HIV-1 infection and methods of use thereof
08/09/2011US7994145 Bicyclonucleoside analogues
08/09/2011US7994144 Ex vivo gene therapy for HIV; formulation of CD34+ hematopoietic cells transduced with a viral construct which expresses an anti-HIV agent such as a ribozyme
08/09/2011US7994143 Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates
08/09/2011US7994142 Agents containing folic acid, vitamin B6 and vitamin B12, and the use thereof
08/09/2011US7994141 Compositions comprising compounds of natural origin for damaged skin
08/09/2011US7994140 Classes of compounds that interact with GPCRs
08/09/2011US7994139 Antiviral therapeutic agents
08/09/2011US7994132 polypeptides that stimulate the formation and cycling of pre-beta high density lipoproteins, promote lipid transport and detoxification, inhibit osteoporosis and atherosclerosis, intensify the activity anticholesterol agents, causing them to be significantly more antiinflammatory at any given dosage
08/09/2011US7994120 Method of treating dyslipidemic disorder
08/09/2011US7994116 Methods for reduction of adhesion formation using cytokine inhibitors
08/09/2011US7994114 Chemokine mimetics synthesis and their use
08/09/2011US7993924 Using myxoviral vector as somatic gene therapeutic tool; genetic vaccines
08/09/2011US7993834 Detection of ErbB2 gene amplification to increase the likelihood of the effectiveness of ErbB2 antibody breast cancer therapy
08/09/2011US7993829 HPRP4s modifiers of the p53 pathway and methods of use
08/09/2011US7993690 Carbohydrate and electrolyte replacement composition
08/09/2011US7993684 Method of inhibiting alveolar bone resorption and periodontal membrane loss and composition for internal use to be used therein
08/09/2011US7993683 Compositions for the treatment of chronic degenerative inflammatory conditions
08/09/2011US7993682 Electrolyte purgative
08/09/2011US7993680 Compositions comprising an ultraviolet radiation-absorbing polymer
08/09/2011US7993678 Hyaluronic acid derivatives
08/09/2011US7993676 Free-flowing, powdery composition containing alpha-liponic acid (derivates)
08/09/2011US7993673 Fast acting paracetamol formulation containing a small amount of antacid
08/09/2011US7993671 Blend of: (a) one or more polymers; and (b) a drug that is liquid ad room temperature; free of water and other low boiling liquids; pressure-sensitive transdermal drug delivery system
08/09/2011US7993670 Medical pad, and method for making and using
08/09/2011US7993669 synergistic efficacy; polar lipid supplement, a soluble fiber, and a nutricine such as threonine
08/09/2011US7993666 Methods and compositions for treating pain comprising a statin
08/09/2011US7993663 Cosmetic use of 1-aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carboxamides and related compounds
08/09/2011US7993659 TLR9 agonist and CD40 agonist immunostimulatory combinations
08/09/2011US7993639 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
08/09/2011US7993635 Menthol-containing formulation
08/09/2011US7993634 Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
08/09/2011US7993374 Supplemental spine fixation device and method
08/09/2011DE202011004855U1 Arznei- oder Nahrungsergänzungsmittel zur Behandlung und/oder Prophylaxe von Erkrankungen Medicinal or dietary supplement for the treatment and / or prophylaxis of diseases
08/09/2011CA2731346A1 Compounds for the treatment of lysosomal storage diseases
08/09/2011CA2728997A1 Pharmaceutical composition of levamlodipine or pharmaceutically acceptable salt thereof and .beta. receptor blocking agent, and use thereof
08/09/2011CA2688709C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
08/09/2011CA2688708C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
08/09/2011CA2688695C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
08/09/2011CA2688694C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
08/09/2011CA2687924C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
08/09/2011CA2665195C Imidazo- and triazolo-pyridine compounds and methods of use thereof
08/09/2011CA2662766C Diaryl ether derivatives and uses thereof
08/09/2011CA2625554C Enteric soft capsule comprising valproic acid
08/09/2011CA2617991C N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
08/09/2011CA2612398C Helix 12 directed non-steroidal antiandrogens
08/09/2011CA2607359C Compounds and methods for the treatment or prevention of flavivirus infections
08/09/2011CA2596994C Hydroalcoholic antimicrobial composition with skin health benefits
08/09/2011CA2591846C Oral compositions containing biphenol antibacterial compounds
08/09/2011CA2584246C Crystalline forms of 3-[5-chloro-4-[(2,4-difluorobenzyl)oxy]-6-oxopyrimidin-1(6h)-yl]-n-(2-hydroxyethyl)-4-methylbenzamide
08/09/2011CA2572208C 3-carbamoyl-2-pyridone derivative
08/09/2011CA2568640C Pharmaceutical composition containing irbesartan